Progress in research of economic evaluation of non-pharmaceutical interventions for COVID-19 prevention and control
10.3760/cma.j.cn112338-20220218-00129
- VernacularTitle:新型冠状病毒肺炎非药物干预防控措施经济学评价研究进展
- Author:
Yaqun FU
1
;
Jingyu ZHAO
;
Peien HAN
;
Li YANG
;
Tao REN
;
Siyan ZHAN
;
Liming LI
Author Information
1. 北京大学公共卫生学院，北京 100191
- Keywords:
COVID-19;
Disease burden;
Non-pharmaceutical intervention;
Economic evaluation
- From:
Chinese Journal of Epidemiology
2022;43(7):1030-1037
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To understand the research progresses of economic evaluation of non-pharmaceutical interventions (NPIs) both at home and abroad, and provide reference for economic evaluation of NPIs using real-world data in China.Methods:The literature retrieval was conducted by searching Chinese and English databases to indude papers about economic evaluation of NPIs and integrated NPIs published from January, 2020 to December, 2021, and the results were analyzed comprehensively.Results:A total of 30 Chinese and English literatures about economic evaluation of NPIs for COVID-19 prevention and control were included; including 7 papers about nucleic acid and testing and screening, 6 papers about individual prevention and protection measures, 12 papers about integrated implementation of individual prevention and protection, social distancing, nucleic acid or antigen testing, community screening and symptom screening, as well as close contact tracing and isolation/quarantine, and 5 papers about contain strategies, such as lockdown. This study found that personal protection, social distancing, and testing-tracing-isolation measures were cost-effective; however, different combinations of NPIs might lead to different results. Moreover, the cost of lockdown was high, which might cause huge economic burden.Conclusions:Most NPIs are cost-effective except lockdown, while the cost-effectiveness of the integrations of NPIs at different levels and in different scenarios needs to be further evaluated. It is necessary to carry out economic evaluation of integrated NPIs and the combination of NPIs with other interventions, such as vaccination and medication, based on real-world settings in China.
